ArticleJournal of experimental & clinical cancer research : CR2021
Correction to: MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
Guangbing Xiong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.